# Paolo Gisondi

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/paolo-gisondi/

## Facts

| Field | Value |
| --- | --- |
| Citations | 17,887 |
| Field | Psoriasis: Treatment and Pathogenesis |
| h-index | 66 |
| i10-index | 253 |
| Last Known Institution | University of Verona |
| OpenAlex ID | https://openalex.org/A5087192032 |
| ORCID iD | https://orcid.org/0000-0002-1777-9001 |
| Works | 504 |

## Researcher papers

- [European S3‐Guidelines on the systemic treatment of psoriasis vulgaris](https://scholariq.org/papers/european-s3-guidelines-on-the-systemic-treatment-of-psoriasis-vulgaris/)
- [Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case?control study](https://scholariq.org/papers/prevalence-of-metabolic-syndrome-in-patients-with-psoriasis-a-hospital-based/)
- [Prevalence of psoriatic arthritis in patients with psoriasis: A systematic review and meta-analysis of observational and clinical studies](https://scholariq.org/papers/prevalence-of-psoriatic-arthritis-in-patients-with-psoriasis-a-systematic-review/)
- [Recategorization of psoriasis severity: Delphi consensus from the International Psoriasis Council](https://scholariq.org/papers/recategorization-of-psoriasis-severity-delphi-consensus-from-the-international/)
- [Prevalence of most common skin diseases in Europe: a population‐based study](https://scholariq.org/papers/prevalence-of-most-common-skin-diseases-in-europe-a-population-based-study/)
- [Italian guidelines on the systemic treatments of moderate‐to‐severe plaque psoriasis](https://scholariq.org/papers/italian-guidelines-on-the-systemic-treatments-of-moderate-to-severe-plaque/)
- [Evidence for a ‘window of opportunity’ in hidradenitis suppurativa treated with adalimumab: a retrospective, real‐life multicentre cohort study*](https://scholariq.org/papers/evidence-for-a-window-of-opportunity-in-hidradenitis-suppurativa-treated-with/)
- [Factors associated with adverse COVID-19 outcomes in patients with psoriasis—insights from a global registry–based study](https://scholariq.org/papers/factors-associated-with-adverse-covid-19-outcomes-in-patients-with-psoriasis/)

## Researcher topics

- [Psoriasis: Treatment and Pathogenesis](https://scholariq.org/topics/psoriasis-treatment-and-pathogenesis/)
- [Spondyloarthritis Studies and Treatments](https://scholariq.org/topics/spondyloarthritis-studies-and-treatments/)
- [Dermatology and Skin Diseases](https://scholariq.org/topics/dermatology-and-skin-diseases/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Autoimmune Bullous Skin Diseases](https://scholariq.org/topics/autoimmune-bullous-skin-diseases/)

## Researcher university

- [University of Verona](https://scholariq.org/institutions/university-of-verona/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.